Levonorgestrel and Ethinyl Estradiol

This page contains recent news articles, when available, and an overview of Levonorgestrel and Ethinyl Estradiol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

… FDA Approval For Levonorgestrel And Ethinyl Estradiol Tablets USP,...  -  Jun 2, 2006
For the 12-months ending March 2006, the levonorgestrel and ethinyl estradiol tablets USP, 0.1mg / 0.02mg market had total US sales of approximately $28 ... Medical News Today - Medical News Today (press release)

… Receives FDA Approval for Levonorgestrel and Ethinyl Estradiol...  -  Jun 1, 2006
Watson Pharmaceuticals Receives FDA Approval for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1mg / 0.02mg. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Watson Files FDA Application for Generic LYBREL(R). - ...  -  Mar 13, 2008
Watson's Levonorgestrel and Ethinyl Estradiol product is a generic version of Wyeth's LYBREL(R) (levonorgestrel and ethinyl estradiol) tablets which is ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: First Scientific Data for Lybrel(TM) Presented at ASRM...  -  Oct 17, 2005
12-months ending March 2006, the levonorgestrel and ethinyl estradiol tablets USP, 0.1mg / 0.02mg market had total U.S ... ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: /CORRECTION -- Watson Pharmaceuticals, Inc./. - PR …  -  Dec 30, 2008
Application for levonorgestrel and ethinyl estradiol tablets USP, 0.1mg / 0.02mg ... according to IMS Health data. About Watson Pharmaceuticals, Inc. Watson ... Pay-Per-View - PR Newswire - HighBeam Research

AAP updates policy on adolescent contraception.(News) | Article from ...  -  Dec 1, 2007
In particular, the AAP noted that the two FDA-approved medications--Preven (levonorgestrel and ethinyl estradiol) and Plan B--are safe and effective for ... Pay-Per-View - Pediatric News - HighBeam Research

Article: Study says oral contraceptives ameliorate premenstrual …  -  Oct 1, 2005
Levonorgestrel and Ethinyl Estradiol Tablets ... triphasic regimen oral contraceptive drug product ... levonorgestrel and ethinyl estradiol triphasic ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research

Barr's Seasonique Won't Need New Data  -  Mar 17, 2006
The Seasonale treatment includes a combination pill of the drugs levonorgestrel and ethinyl estradiol for 84 days, then a placebo for 7 days. ... TheStreet.com - TheStreet.com (subscription)

Press Release: Watson Pharmaceuticals Receives FDA Approval for …  -  Aug 1, 2005
PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty ... levonorgestrel and ethinyl estradiol tablets USP, 0.1mg / 0.02mg, ... Pay-Per-View - PR Newswire - HighBeam Research

Barr Pulls Lo Seasonale Filing  -  Apr 6, 2006
Seasonique requires women to take a pill combining levonorgestrel and ethinyl estradiol for 84 consecutive days, followed by seven days of ethinyl estradiol ... TheStreet.com - TheStreet.com (subscription)

FDA Asks Wyeth for More Drug Data  -  Jun 28, 2006
Seasonique requires women to take a pill combining levonorgestrel and ethinyl estradiol for 84 consecutive days, followed by seven days of a separate ... TheStreet.com - TheStreet.com (subscription)

Wyeth Contraceptive Approved  -  May 23, 2007
Lybrel contains levonorgestrel and ethinyl estradiol, which are active ingredients available in other approved oral contraceptives. ... TheStreet.com - TheStreet.com (subscription)

FDA Wants More Data From Barr  -  Jul 25, 2005
The Seasonale treatment requires women to take a combination pill of the drugs levonorgestrel and ethinyl estradiol for 84 days, then take a placebo for 7 ... TheStreet.com - TheStreet.com (subscription)

Berlex.(Pipeline) | Article from Medical Marketing & Media | HighBeam...  -  Mar 1, 2007
Duramed, a unit of Barr Pharmaceuticals, has acquired exclusive rights for Nordette (levonorgestrel and ethinyl estradiol) tablets from King Pharmaceuticals ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Press Release: Watson Files Application for Generic SEASONIQUE(R). - ...  -  Mar 4, 2008
...to market its levonorgestrel and ethinyl estradiol (0.15 mg/0.03 mg) ... Inc. Watson's levonorgestrel and ethinyl estradiol product is a generic version ... Pay-Per-View - PR Newswire - HighBeam Research

STEPS - American Family Physician  -  Jan 15, 2008
Levonorgestrel and ethinyl estradiol are used in several other combination products that have demonstrated long-term safety. Safety of the continuous use of ... AAFP News Now

Press Release: Data Show Low Incidence of Breakthrough Bleeding With ...  -  May 9, 2007
100 mcg levonorgestrel/20 mcg ethinyl estradiol tablets), a new low-dose birth ... combination of levonorgestrel and ethinyl estradiol marketed in the ... Pay-Per-View - PR Newswire - HighBeam Research

Year-round contraception safely ends periods  -  Dec 14, 2006
NEW YORK (Reuters Health) - Continuous treatment with an oral contraceptive combination of levonorgestrel and ethinyl estradiol (LNG/EE) can safely ... Reuters

Sperm stopped in their tracks by vaginal gel contraceptive  -  Oct 3, 2007
Meanwhile, Wyeth received US approval earlier this year for the contraceptive pill Lybrel (levonorgestrel and ethinyl estradiol), which taken every day not ... DrugResearcher.com

Paladin Reports 2008 First Quarter Financial Results  -  May 15, 2008
Seasonale TM (levonorgestrel and ethinyl estradiol 0.15mg/0.03mg tablets) is a safe and effective contraceptive option for women, striking a balance between ... marketwire.com

New Low Estrogen Contraceptive Patch Completes Phase 2 Study.  -  Nov 28, 2005
The Agile patch is designed to deliver levonorgestrel and ethinyl estradiol, the same hormone combination found in many oral contraceptives with ... $4.95 - PR Newswire - ECNext

Press Release Distribution from 24-7PressRelease.com  -  Nov 9, 2007
.../24-7PressRelease/ - CHICAGO, IL, November 09, 2007 - US Food & Drug Administration (FDA) has approved Lybrel (levonorgestrel and ethinyl estradiol) on May ... 24-7pressrelease.com

Wyeth Provides Status Update On TRIPHASIL-28 And ALESSE Oral …  -  Aug 7, 2006
Wyeth (NYSE:WYE) announced that the company has designated both TRIPHASIL®-28 (levonorgestrel and ethinyl estradiol tablets-triphasic regimen) and ALESSE® ... Medical News Today - Medical News Today (press release)

Press Release: Agile Therapeutics Achieves Phase 2 Study Endpoints in...  -  Sep 3, 2008
Its lead product is a 7-day combination contraceptive patch delivering levonorgestrel and ethinyl estradiol. The Company has conducted a number of clinical ... Pay-Per-View - PR Newswire - HighBeam Research

Clinical Trials; Pharma development company completes phase II study...  -  Dec 26, 2005
The Agile patch is designed to deliver levonorgestrel and ethinyl estradiol, the same hormone combination found in many oral contraceptives with ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones

Press Release: Agile Therapeutics Abstracts on Lead Product, AG200-15...  -  Dec 9, 2008
The two abstracts scheduled for poster presentation are: (1) Pharmacokinetics: Contraceptive Patches Containing Levonorgestrel and Ethinyl Estradiol vs. ... Pay-Per-View - PR Newswire - HighBeam Research

Clinical Trials; Pharma development company completes phase II study...  -  Dec 27, 2005
The Agile patch is designed to deliver levonorgestrel and ethinyl estradiol, the same hormone combination found in many oral contraceptives with ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Women's Menstrual Cycles Can Be Seasonal with SEASONALE TM : First …  -  Jul 5, 2007
SEASONALE, (levonorgestrel and ethinyl estradiol 0.15mg/0.03 mg tablets), is a safe and effective contraceptive option for women, striking a balance between ... marketwire.com

Plan B decision delayed as FDA seeks comment: difficult regulatory …  -  Sep 15, 2005
Preven, an emergency contraceptive that contains levonorgestrel and ethinyl estradiol, was approved in 1998. Plan B has had a rocky road in the quest for ... Free with registration - OB GYN News - AccessMyLibrary.com

Year-round contraception safely ends periods .  -  Dec 15, 2006
NEW YORK reuters Health) Continuous treatment with- an oral contraceptive combination of levonorgestrel and ethinyl estradiol can safely eliminate menstrua ... Daily News - Google News Archive

Paladin Reports Record 2007 Fourth Quarter and Year End Results  -  Feb 28, 2008
Seasonale TM , (levonorgestrel and ethinyl estradiol 0.15mg/0.03mg tablets), is a safe and effective contraceptive option for women, striking a balance ... marketwire.com

Paladin Reports 2007 Record Third Quarter Financial Results  -  Nov 1, 2007
Seasonale(TM), (levonorgestrel and ethinyl estradiol 0.15mg/0.03 mg tablets), is a safe and effective contraceptive option for woman, striking a balance ... Web Services Journal - Web Services Journal

Watson files for generic copy of Wyeth's Lybrel drug  -  Mar 14, 2008
...to the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application (ANDA) regarding Wyeth's levonorgestrel and ethinyl estradiol drug. ... Hays Pharma

Watson gets FDA OK for Seasonale clone.  -  Sep 7, 2006
The agency approved Watson's application to sell tablets containing 0.15 milligrams levonorgestrel and ethinyl estradiol 0.03 milligrams, ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com

Paladin Reports 2007 Record Second Quarter Financial Results  -  Aug 2, 2007
Seasonale TM , (levonorgestrel and ethinyl estradiol 0.15mg/0.03 mg tablets), is a safe and effective contraceptive option for women, striking a balance ... marketwire.com

Healthcare: At a Glance - Wyeth to shake up contraceptive market.  -  Oct 28, 2005
Wyeth Pharmaceuticals is looking to launch an oral contraceptive, called Lybrel, which combines the chemicals levonorgestrel and ethinyl estradiol. ... Free with registration - PR Week - AccessMyLibrary.com

Wyeth Presents R&D Highlights at Investor Conference.  -  Oct 5, 2006
Lybrel(TM) is an investigational oral contraceptive that contains a low dose of levonorgestrel and ethinyl estradiol, a well-studied combination. ... Free with registration - PR Newswire - AccessMyLibrary.com

Paladin Labs and Procter & Gamble Pharmaceuticals Enter Into …  -  Jul 2, 2008
SEASONALE(TM) (levonorgestrel and ethinyl estradiol 0.15mg/0.03 mg tablets) is an effective new contraceptive option for Canadian women, striking a balance ... Genetic Engineering News - Genetic Engineering News (press release)

Thomson Scientific Publishes The Ones to Watch - A Quarterly Review...  -  Aug 16, 2007
Second on our list is Wyeth, which is marketing Lybrel(TM) -- a combination of Levonorgestrel and ethinyl estradiol in a daily oral tablet which eliminates ... Free with registration - PR Newswire - AccessMyLibrary.com

Medical Notes  -  Oct 3, 2005
The study investigates Levonorgestrel and Ethinyl Estradiol in the treatment of Premenstrual Dysphoric Disorder. Dr. Gwenesta Melton is the lead physician ... $2.95 - Fayetteville Observer - NewsBank

Paladin Labs Announces SEASONALE Launch  -  Jan 4, 2008
SEASONALE TM , (levonorgestrel and ethinyl estradiol 0.15mg/0.03mg tablets), is a safe and effective contraceptive option for women, striking a balance ... marketwire.com

Barr's Portia approved and launched in Canada.(Barr Pharmaceuticals...  -  Sep 3, 2007
Min-Ovral (levonorgestrel and ethinyl estradiol) tablets. This represents the first approval of a generic oral contraceptive for Canadian consumers. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Barr's Duramed acquires exclusive rights to Nordette.(Brief Article)  -  Jan 3, 2005
Duramed Pharmaceuticals, has acquired from King the exclusive rights in the USA for Nordette (levonorgestrel and ethinyl estradiol) tablets. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Facts about Oral Contraceptives, especially Alesse  -  Nov 21, 2007
Levonorgestrel and ethinyl estradiol are the active, generic ingredients found in Alesse. Use 'back up' (spermicide and a condom) to begin with if this is ... Buzzle

Paladin Launches Seasonale in Canada  -  Jan 7, 2008
The company said that, with Seasonale (levonorgestrel and ethinyl estradiol 0.15mg/0.03mg tablets), Canadian women now have a new contraceptive option that ... RedOrbit

Duramed.(Pipeline)  -  Feb 1, 2005
Duramed, a unit of Barr Pharmaceuticals, has acquired exclusive rights for Nordette (levonorgestrel and ethinyl estradiol) tablets from King Pharmaceuticals ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Article: The Center for Reproductive Rights.(Update) - Medical...  -  Sep 1, 2006
Duramed, a unit of Barr Pharmaceuticals, has acquired exclusive rights for Nordette (levonorgestrel and ethinyl estradiol) tablets from King Pharmaceuticals ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Agile Therapeutics Wins Patent for Transdermal Technology in …  -  Oct 30, 2008
...providing women with the hormonal combination of levonorgestrel and ethinyl estradiol in a low-dose, weekly contraceptive patch that is comfortable to ... RedOrbit

FDA warns Wyeth about Puerto Rico plant.  -  Jun 5, 2006
...processing, packing and holding of the human drug products made there, including the contraceptive Triphasil-21 (levonorgestrel and ethinyl estradiol). ... $9.94 - Pharma Marketletter - Alacra Store

Contraceptive Guide to Pregnancy  -  Mar 13, 2008
Alesse, as you know, is an oral contraceptive that contains two synthetic hormones to stop you from getting pregnant- Levonorgestrel and ethinyl estradiol ... Buzzle

GBCFinancial.com's commentary news features: EMTI , MOT , KG , BRL, …  -  Jan 5, 2005
Inc., has acquired from King the exclusive rights in the United States for Nordette(R) (levonorgestrel and ethinyl estradiol) Tablets. ... $4.95 - M2 Presswire - ECNext

To bleed or not to bleed: new options in the birth control arsenal.  -  Nov 1, 2007
The active tablets in all of these pills contain a combination of levonorgestrel and ethinyl estradiol. The difference lies in the way a woman takes her ... $4.95 - Women's Health Activist - ECNext

Factiva Search  -  Jun 1, 2006
Watson Pharmaceuticals receives FDA approval for levonorgestrel and ethinyl estradiol tablets USP, 0.1 mg / 0.02 mg. 01 June, 2006 Company Reports ... Pay-Per-View - Company Reports - Factiva, from Dow Jones

Press Release: The Ferrari Of Condoms, Inspiral, Becomes More …  -  Aug 8, 2005
PR Newswire; April 19, 1994 ; 700+ words ... ... levonorgestrel and ethinyl estradiol tablets) Safer Sex Initiative(TM), a program that will . ... Pay-Per-View - PR Newswire - HighBeam Research

First-time generic approvals.(FDA Drug Approvals)  -  Nov 1, 2006
Levonorgestrel and ethinyl estradiol tablets, 0.15/0.03 mg (equiv to Seasonale tablets) WATSON Diltiazem extended-release capsules, 120, 180, 240, 300, 360, ... $4.95 - Formulary - ECNext

Press Release: Ready two Go(TM) Brings New Stylish FUN to Safer Sex. ...  -  Feb 19, 2008
PR Newswire; April 19, 1994 ; 700+ words ... ... levonorgestrel and ethinyl estradiol tablets) Safer Sex Initiative(TM), a program that will . ... Pay-Per-View - PR Newswire - HighBeam Research

Collaborations; Pharmaceutical firm acquires exclusive rights to...  -  Jan 29, 2005
Inc., has acquired from King the exclusive rights in the United States for Nordette (levonorgestrel and ethinyl estradiol) Tablets. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Collaborations; Pharmaceutical firm acquires exclusive rights to...  -  Jan 25, 2005
Inc., has acquired from King the exclusive rights in the United States for Nordette (levonorgestrel and ethinyl estradiol) Tablets. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Agile Therapeutics SKINFUSION technology gets two US patents.  -  Oct 28, 2008
SKINFUSION technology enables the utilization of the trusted hormone combination of levonorgestrel and ethinyl estradiol in a contraceptive patch. ... $9.94 - M2 Europharma - Alacra Store

Barr Laboratories.(Pipeline) | Article from Medical Marketing & Media...  -  Jun 1, 2005
Barr Laboratories reported that the FDA has approved the Seasonale (levonorgestrel and ethinyl estradiol) 0.15mg/ 0.03mg tablets, an extended ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Not all oral contraceptives are alike.  -  Aug 4, 2008
...promotion and trade distribution support to Paladin Labs Inc.'s Seasonale (levonorgestrel and ethinyl estradiol), the first and only extended-cycle oral ... $9.94 - Chain Drug Review - Alacra Store

New generics.  -  Jan 10, 2005
Watson Pharmaceuticals, Corona, Calif., (909) 270-1400, is introducing levonorgestrel and ethinyl estradiol tablets USP in 0.1 mg/0.02 mg for the prevention ... $9.94 - Drug Topics - Alacra Store

Watson Pharmaceuticals.  -  Jan 17, 2005
Watson Pharmaceuticals received final approval for and began shipment of levonorgestrel and ethinyl estradiol tablets USP, 0.1 mg/0.02 mg, ... $9.94 - Drug Store News - Alacra Store

Collaborations; Pharmaceutical firm acquires exclusive rights to...  -  Jan 24, 2005
Inc., has acquired from King the exclusive rights in the United States for Nordette (levonorgestrel and ethinyl estradiol) Tablets. ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy